AI-generated summary
The authors ran a placebo-controlled, double-blind trial of GaAs laser therapy in patients with cervical myofascial pain syndrome, comparing an active laser group with a sham group. Both groups improved significantly in pain, algometry and cervical flexion, but the authors report no significant difference between the active and placebo groups, so superiority of the laser was not shown.
- Participants
- 53
- Who or what was studied
- Patients with cervical myofascial pain syndrome (53 enrolled, 48 evaluated; 32 female and 16 male in the evaluated group)
- Limits stated in the abstract
- The abstract states results were analyzed in 48 of 53 enrolled patients, and the authors suggest further studies in larger populations using different laser types and dosages.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Placebo-controlled. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.